Etoposide (BluePoint Laboratories)
Welcome to the PulseAid listing for the Etoposide drug offered from BluePoint Laboratories. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | BluePoint Laboratories |
| NON-PROPRIETARY NAME: | Etoposide |
| SUBSTANCE NAME: | ETOPOSIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-11-14 |
| END MARKETING DATE: | 0000-00-00 |
Etoposide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Etoposide from BluePoint Laboratories |
| LABELER NAME: | BluePoint Laboratories |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 2013-11-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68001-265_a9427b53-863a-4c9f-a458-aedbd9455184 |
| PRODUCT NDC: | 68001-265 |
| APPLICATION NUMBER: | ANDA074513 |
Other ETOPOSIDE Pharmaceutical Manufacturers / Labelers:
